Federal contract award

75N95021P00678

PURPOSE: TO PROVIDE THE NINDS OFFICE OF THE CLINICAL DIRECTOR (OCD) AND SURGICAL NEUROLOGY BRANCH (SNB) WITH RNA SEQUENCING ON 87 FROZEN AND 16 MATCHED PLASMA BRAIN TUMOR/GLIOMA SAMPLES. NEW YORK GENOME CENTER, INC. 09.27.2021 - 01.26.2022

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIDA
NAICS541380 — Testing Laboratories and Services
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$52.5K
Current contract value$52.5K
Potential contract value / ceiling$52.5K
Start dateSep 24, 2021
Current end dateJan 26, 2022
Potential end dateJan 26, 2022
Latest award activitySep 24, 2021
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 11, 2026P00001$-16.3KTO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Sep 24, 20210$52.5KPURPOSE: TO PROVIDE THE NINDS OFFICE OF THE CLINICAL DIRECTOR (OCD) AND SURGICAL NEUROLOGY BRANCH (SNB) WITH RNA SEQUENCING ON 87 FROZEN AND 16 MATCHED PLASMA BRAIN TUMOR/GLIOMA SAMPLES. NEW YORK GENOME CENTER, INC. 09.27.2021 - 01.26.2022

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.